New York Pharmaceutical Whistleblower Attorney

The United States controls over 50% of the global pharmaceutical industry, with U.S. companies holding a near $1 trillion valuation. Nationally recognized New York hospitals such as Mount Sinai, New York-Presbyterian, and Sloan Kettering contribute to the demand for cutting-edge pharmaceuticals from NY-headquartered Big Pharma companies such as Pfizer, Kadmon, and Bristol Myers Squibb. Unfortunately, this high-stakes and highly regulated industry is inundated with fraud.

Do not take on these multi-trillion-dollar corporations alone. Confidentially discuss blowing the whistle on Big Pharma fraud with experienced whistleblower claims defense lawyer Peter Katz in New York.

Common Types of Pharmaceutical Fraud in New York

Fraud at major pharmaceutical companies generally falls into the following categories:

Research and Development (R&D)/Clinical Trial Fraud

Despite investing billions in R&D each year, the FDA only approves about 50 new prescription drugs annually. Many companies will exaggerate or falsify clinical trial data to increase their chances of approval, recover their investments, and gain industry acclaim. This type of fraud generally includes:

• Hiding conflicts of interest
• Falsifying data
• Altering participant records
• Failing to obtain informed consent
• Underreporting side effects
• Misrepresenting results

If you suspect clinical trial fraud as a participant, researcher, or medical professional, discuss your options for blowing the whistle now to prevent life-threatening results.

Off-Label Marketing

Both Big Pharma and medical device companies may market and sell their products for unapproved uses. For example, Botox once marketed its product to treat migraines, but the FDA did not approve it for that purpose. New York-area pharmaceutical reps and insiders should immediately contact whistleblower protection lawyer Peter Katz in such cases.

Fraudulent Billing (Medicare and Medicaid Fraud)

When pharmaceutical companies overbill public health insurance providers such as Medicare and Medicaid, whistleblowers can file private lawsuits under the New York or federal False Claims Act (FCA). The FCA gives whistleblowers the right to sue the pharmaceutical company on behalf of the government by filing a ‘qui tam’ lawsuit. Eligible whistleblowers with original information about suspected fraud can obtain between 15 and 30% of the government’s overall financial recovery, which can be millions in pharmaceutical fraud cases. The FCA also contains critical anti-retaliation protections for whistleblowing pharmaceutical employees.

Working with Federal Law Enforcement Agencies to Expose NY R&D and Prescription Drug Fraud

If you have evidence of potential major fraud by a leading pharmaceutical company, former federal prosecutor Peter Katz can recommend working directly with federal law enforcement authorities. You should always retain private legal counsel in such cases, as an experienced whistleblower lawyer can ensure you’re not prosecuted for any alleged involvement in the scheme.

If another employee blows the whistle before you or the FBI, DEA, or FDA has an open investigation, it may be too late to blow the whistle. Exposing potential pharmaceutical fraud in good faith now may be the best option for protecting yourself and recovering financial damages.

Call a Trusted Pharmaceutical Whistleblower Lawyer in New York

From identifying falsified clinical trial data to exposing dangerous off-label marketing schemes, pharmaceutical whistleblowers in New York have the rare potential to save lives. Confidentially discuss the benefits and protections afforded to Big Pharma whistleblowers in NY with experienced pharmaceutical whistleblower protection attorney Peter Katz by calling (609) 849-3179 or connecting with his legal team online.